Powered by

Did You Invest in Gilead Sciences?; Gibbs Law Group Investigates Potential Securities Law Claims on Behalf of Investors

Nov 08, 2019 - Business Wire

The U.S. Government has filed a lawsuit accusing Gilead Sciences of violating patents owned by the U.S. Department of Health and Human Services related to Truvada, Gilead's HIV prevention drug. Gibbs Law Group has launched a Gilead Sciences Investor Lawsuit investigation on behalf of those who invested in Gilead Sciences (NASDAQ: GILD).

To speak with an attorney regarding this lawsuit investigation, click here or call (888) 410-2925.

On November 6, 2019, the U.S. Department of Health...